Pharmaceuticals and Medical Devices Agency

Events and Symposia

Public comments

What's new

Back number

December 8, 2025

Drug

IVD

New

PMDA Risk Communications: Aspirin-etc. posted
December 5, 2025

Regen.

New

PMDA Risk Communication: Idecabtagene vicleucel etc. posted
November 26, 2025

Regen.

Revisions of PRECAUTIONS: Onasemnogene abeparvovec posted
November 26, 2025

Drug

IVD

Revisions of PRECAUTIONS: Bosentan hydrate, etc. posted
November 25, 2025

All

MHLW Pharmaceuticals and Medical Devices Safety Information No.424 posted

Back number

Currently, there is no applicable information.

Back number

Currently, there is no applicable information.

Back number

Services of PMDA

Reviews and Related Services

Clinical trials, reviews, consultations, compliance assessments, and inspections concerning applications for drugs, medical devices, regenerative medical products, etc.

Post-marketing Safety Measures

Collection and provision of information regarding post-marketing safety and scientific research and analyses on data collected.

Relief Services for Adverse Health Effects

Relief Systems for Adverse Drug Reactions.

Regulatory Science

Regulatory science research, the Science Board, projects across multi-offices in PMDA, and standards development (e.g., Japanese Pharmacopoeia, medical device standards).

International Activities

International harmonization activities such as collaboration with overseas regulatory authorities and international organizations, participation in international meetings including ICH, and activities related to Asia Training Center.